Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: Fierce 15 nominations are now open! We're looking for the best and brightest in biotech.
Takeda
Biotech
Takeda pays AC Immune $100M upfront for a ph. 2 Alzheimer's drug
AC Immune is evaluating ACI-24.06 in a phase 1b/2 trial in both in subjects with prodromal Alzheimer’s disease and in adults with Down syndrome.
James Waldron
May 13, 2024 5:51am
Takeda culls cancer, gut and inflammation drugs in R&D rethink
May 9, 2024 5:13am
Neurocrine-Takeda antidepressant hits main mark in phase 2 trial
Apr 23, 2024 10:44am
Takeda inks sweet $1.2B-plus immuno-oncology deal with Kumquat
Apr 16, 2024 11:34am
'The Top Line': Inclusivity in psoriasis trials with Takeda
Mar 15, 2024 7:00am
Amid pivot, Denali Therapeutics sends staff packing
Feb 26, 2024 12:22pm